India Glycols Limited (IGL) is a leading producer of Ethlyene Glycol, Di-Ethyl Glycol, EO Deravatives and Heavy Glycol. The company also produces MEG (Mono Ethylene Glycol), an important intermediate for fibre manufacture. In Ethoxylates, it is the m... More
Thirumalai Chemicals Limited (TCL) manufactures and markets organic acids, anhydrides and derivatives for the plastics, paints, resin industries and additives for the food and feed industry. Its plant is situated at Ranipet (South India) and Kemaman ... More
INDIA GLYCOLS | THIRUMALAI CHEMICALS | INDIA GLYCOLS/ THIRUMALAI CHEMICALS |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 8.9 | 39.7 | 22.5% | View Chart |
P/BV | x | 1.2 | 1.4 | 86.6% | View Chart |
Dividend Yield | % | 1.6 | 22.3 | 7.3% |
![]() ![]() |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
INDIA GLYCOLS Mar-19 |
THIRUMALAI CHEMICALS Mar-19 |
INDIA GLYCOLS/ THIRUMALAI CHEMICALS |
5-Yr Chart Click to enlarge
|
||
High | Rs | 620 | 2,416 | 25.7% | |
Low | Rs | 233 | 67 | 347.8% | |
Sales per share (Unadj.) | Rs | 1,084.2 | 1,231.5 | 88.0% | |
Earnings per share (Unadj.) | Rs | 42.8 | 110.9 | 38.6% | |
Cash flow per share (Unadj.) | Rs | 67.5 | 146.4 | 46.1% | |
Dividends per share (Unadj.) | Rs | 6.00 | 20.00 | 30.0% | |
Dividend yield (eoy) | % | 1.4 | 1.6 | 87.3% | |
Book value per share (Unadj.) | Rs | 310.9 | 652.2 | 47.7% | |
Shares outstanding (eoy) | m | 30.96 | 10.24 | 302.3% | |
Bonus/Rights/Conversions | - | - | - | ||
Price / Sales ratio | x | 0.4 | 1.0 | 39.0% | |
Avg P/E ratio | x | 10.0 | 11.2 | 88.9% | |
P/CF ratio (eoy) | x | 6.3 | 8.5 | 74.6% | |
Price / Book Value ratio | x | 1.4 | 1.9 | 72.1% | |
Dividend payout | % | 14.0 | 18.0 | 77.7% | |
Avg Mkt Cap | Rs m | 13,203 | 12,713 | 103.9% | |
No. of employees | `000 | 1.3 | 0.5 | 272.1% | |
Total wages/salary | Rs m | 1,008 | 456 | 221.0% | |
Avg. sales/employee | Rs Th | 25,332.9 | 25,894.0 | 97.8% | |
Avg. wages/employee | Rs Th | 761.1 | 937.0 | 81.2% | |
Avg. net profit/employee | Rs Th | 1,000.8 | 2,332.0 | 42.9% |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 33,566 | 12,610 | 266.2% | |
Other income | Rs m | 169 | 115 | 146.9% | |
Total revenues | Rs m | 33,735 | 12,726 | 265.1% | |
Gross profit | Rs m | 4,169 | 2,059 | 202.5% | |
Depreciation | Rs m | 762 | 364 | 209.7% | |
Interest | Rs m | 1,435 | 122 | 1,179.0% | |
Profit before tax | Rs m | 2,141 | 1,689 | 126.8% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | -10 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 805 | 553 | 145.6% | |
Profit after tax | Rs m | 1,326 | 1,136 | 116.8% | |
Gross profit margin | % | 12.4 | 16.3 | 76.1% | |
Effective tax rate | % | 37.6 | 32.7 | 114.9% | |
Net profit margin | % | 4.0 | 9.0 | 43.9% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 13,853 | 4,595 | 301.5% | |
Current liabilities | Rs m | 17,250 | 3,281 | 525.8% | |
Net working cap to sales | % | -10.1 | 10.4 | -97.1% | |
Current ratio | x | 0.8 | 1.4 | 57.3% | |
Inventory Days | Days | 70 | 55 | 127.2% | |
Debtors Days | Days | 35 | 33 | 107.3% | |
Net fixed assets | Rs m | 23,103 | 5,420 | 426.3% | |
Share capital | Rs m | 310 | 102 | 302.3% | |
"Free" reserves | Rs m | 9,317 | 6,576 | 141.7% | |
Net worth | Rs m | 9,626 | 6,679 | 144.1% | |
Long term debt | Rs m | 3,961 | 784 | 505.2% | |
Total assets | Rs m | 37,843 | 11,408 | 331.7% | |
Interest coverage | x | 2.5 | 14.9 | 16.8% | |
Debt to equity ratio | x | 0.4 | 0.1 | 350.5% | |
Sales to assets ratio | x | 0.9 | 1.1 | 80.2% | |
Return on assets | % | 7.3 | 11.0 | 66.2% | |
Return on equity | % | 13.8 | 17.0 | 81.0% | |
Return on capital | % | 26.2 | 24.3 | 108.2% | |
Exports to sales | % | 24.2 | 7.9 | 304.9% | |
Imports to sales | % | 46.5 | 6.7 | 696.2% | |
Exports (fob) | Rs m | 8,115 | 1,000 | 811.5% | |
Imports (cif) | Rs m | 15,622 | 843 | 1,853.1% | |
Fx inflow | Rs m | 8,631 | 1,000 | 863.1% | |
Fx outflow | Rs m | 16,858 | 843 | 1,999.8% | |
Net fx | Rs m | -8,227 | 157 | -5,240.4% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,471 | 2,339 | 62.9% | |
From Investments | Rs m | -1,281 | -2,204 | 58.1% | |
From Financial Activity | Rs m | 30 | 158 | 19.1% | |
Net Cashflow | Rs m | 219 | 291 | 75.4% |
Indian Promoters | % | 61.1 | 46.6 | 131.1% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 2.0 | 0.1 | 2,000.0% | |
FIIs | % | 0.0 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 36.9 | 53.3 | 69.2% | |
Shareholders | 33,622 | 16,178 | 207.8% | ||
Pledged promoter(s) holding | % | 0.9 | 0.0 | - |
Compare INDIA GLYCOLS With: BASF INDIA ATUL NAVIN FLUORINE MONSANTO INDIA AARTI INDUSTRIES
Indian share markets witnessed huge selling pressure today and failed to hold on to their opening gains as profit booking and weakness across all sectors erased gains.
For the quarter ended December 2019, INDIA GLYCOLS has posted a net profit of Rs 293 m (down 16.2% YoY). Sales on the other hand came in at Rs 15 bn (up 23.1% YoY). Read on for a complete analysis of INDIA GLYCOLS's quarterly results.
For the quarter ended September 2019, THIRUMALAI CHEMICALS has posted a net profit of Rs 99 m (down 81.3% YoY). Sales on the other hand came in at Rs 3 bn (down 26.1% YoY). Read on for a complete analysis of THIRUMALAI CHEMICALS's quarterly results.
Here's an analysis of the annual report of THIRUMALAI CHEMICALS for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of THIRUMALAI CHEMICALS. Also includes updates on the valuation of THIRUMALAI CHEMICALS.
Here's an analysis of the annual report of INDIA GLYCOLS for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of INDIA GLYCOLS. Also includes updates on the valuation of INDIA GLYCOLS.
For the quarter ended June 2019, INDIA GLYCOLS has posted a net profit of Rs 388 m (down 8.1% YoY). Sales on the other hand came in at Rs 14 bn (up 25.8% YoY). Read on for a complete analysis of INDIA GLYCOLS's quarterly results.
More Views on NewsIn this video, I'll show you why it might be the right time to take money of the table in pharma stocks.
The pandemic failed to thwart Richa's investing success formula for 2020.
In this video, I'll show you a crucial chart that you need to check before you decide to sell any stock or index.
Our ace stock picker is ready to capitalise on a big growth opportunity.
More